- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2305
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2305 companies
INSPECS Group
Market Cap: UK£47.0m
Designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia.
SPEC
UK£0.46
7D
6.2%
1Y
-34.9%
Context Therapeutics
Market Cap: US$63.3m
A biopharmaceutical company, develops products for the treatment of solid tumors.
CNTX
US$0.69
7D
-2.7%
1Y
-65.4%
Apyx Medical
Market Cap: US$62.7m
An energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.
APYX
US$1.54
7D
7.7%
1Y
-3.8%
OKYO Pharma
Market Cap: US$62.4m
A clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.
OKYO
US$1.85
7D
25.0%
1Y
40.2%
Metagenomi
Market Cap: US$62.4m
A genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States.
MGX
US$1.62
7D
-2.4%
1Y
-75.3%
Optiscan Imaging
Market Cap: AU$96.1m
Engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States.
OIL
AU$0.12
7D
-8.0%
1Y
15.0%
Acumen Pharmaceuticals
Market Cap: US$62.4m
A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.
ABOS
US$1.02
7D
-4.7%
1Y
-70.0%
vTv Therapeutics
Market Cap: US$62.0m
A clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases.
VTVT
US$17.76
7D
-15.5%
1Y
-35.9%
Vitrafy Life Sciences
Market Cap: AU$95.5m
Provides cryopreservation solutions in Australia.
VFY
AU$1.50
7D
-9.9%
1Y
n/a
NeueHealth
Market Cap: US$61.2m
A healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States.
NEUE
US$6.75
7D
-2.0%
1Y
13.4%
enVVeno Medical
Market Cap: US$60.0m
A clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease.
NVNO
US$3.35
7D
-7.5%
1Y
-33.1%
Celularity
Market Cap: US$59.6m
A clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases.
CELU
US$2.29
7D
12.3%
1Y
-33.8%
Adicet Bio
Market Cap: US$59.4m
A clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.
ACET
US$0.69
7D
-10.8%
1Y
-53.4%
Alterity Therapeutics
Market Cap: AU$91.3m
Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.
ATH
AU$0.01
7D
0%
1Y
100.0%
SkinBioTherapeutics
Market Cap: UK£43.7m
A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.
SBTX
UK£0.19
7D
-3.8%
1Y
87.5%
Serina Therapeutics
Market Cap: US$58.7m
A biotechnology company, develops drugs to treat neurological diseases and pain.
SER
US$5.85
7D
3.2%
1Y
-40.5%
Medinotec
Market Cap: US$58.7m
Engages in the research and development, production, and sale of medical devices in South Africa, the United States, and internationally.
MDNC
US$5.00
7D
0%
1Y
n/a
PainChek
Market Cap: AU$90.3m
Develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally.
PCK
AU$0.049
7D
16.7%
1Y
58.1%
Mach7 Technologies
Market Cap: AU$90.0m
Provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe, and internationally.
M7T
AU$0.38
7D
0%
1Y
-42.9%
Applied Therapeutics
Market Cap: US$58.0m
A clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States.
APLT
US$0.41
7D
-32.0%
1Y
-90.0%
Vivos
Market Cap: US$57.8m
A radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States.
RDGL
US$0.13
7D
-2.1%
1Y
-9.5%
IceCure Medical
Market Cap: US$57.7m
A commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.
ICCM
US$1.06
7D
1.9%
1Y
2.9%
Arovella Therapeutics
Market Cap: AU$88.8m
A biotechnology company, focuses on the development of therapies for the treatment of cancer in Australia and internationally.
ALA
AU$0.075
7D
-9.6%
1Y
-37.5%
Renovaro
Market Cap: US$57.4m
A pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands.
RENB
US$0.33
7D
1.5%
1Y
-77.0%
TELA Bio
Market Cap: US$57.4m
A commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.
TELA
US$1.44
7D
30.9%
1Y
-75.4%
Verrica Pharmaceuticals
Market Cap: US$57.3m
A dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States.
VRCA
US$0.61
7D
-7.6%
1Y
-92.9%
Vicapsys Life Sciences
Market Cap: US$57.3m
Focuses on the development and commercialization of VICAPSYN, a proprietary product.
VICP
US$1.77
7D
0%
1Y
n/a
Gemina Laboratories
Market Cap: CA$78.0m
A biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada.
GLAB
CA$1.02
7D
-1.0%
1Y
126.7%
ECO Animal Health Group
Market Cap: UK£41.7m
Develops, registers, and markets pharmaceutical products for animals worldwide.
EAH
UK£0.61
7D
-1.6%
1Y
-47.9%
Repare Therapeutics
Market Cap: US$56.1m
A clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States.
RPTX
US$1.32
7D
-1.5%
1Y
-57.7%
Artrya
Market Cap: AU$86.3m
A medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia.
AYA
AU$0.77
7D
6.3%
1Y
163.8%
ImmuCell
Market Cap: US$55.9m
An animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
ICCC
US$6.52
7D
23.7%
1Y
43.8%
Cyberfuels Holding
Market Cap: US$55.6m
Operates as an energy and healthcare company in the United States.
CBRF
US$0.52
7D
-12.5%
1Y
-39.1%
Ikena Oncology
Market Cap: US$55.5m
An oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance.
IKNA
US$1.14
7D
2.7%
1Y
-14.3%
AMJ Global Technology
Market Cap: US$55.1m
Engages in developing mobile software products in the United States.
AMJT
US$0.51
7D
0%
1Y
-65.9%
Outlook Therapeutics
Market Cap: US$55.1m
Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.
OTLK
US$1.60
7D
-8.6%
1Y
-79.7%